Home Cart Sign in  
Chemical Structure| 2084868-04-0 Chemical Structure| 2084868-04-0

Structure of Capzimin
CAS No.: 2084868-04-0

Chemical Structure| 2084868-04-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Capzimin shows > 5-fold selectivity for Rpn11 over the related JAMM proteases and > 2 logs selectivity over several other metalloenzymes.

Synonyms: Capzimin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Capzimin

CAS No. :2084868-04-0
Formula : C30H24N6O2S4
M.W : 628.81
SMILES Code : O=C(C1=CC2=CC=CC(SSC3=C4N=CC(C(NCCC5=NC=CS5)=O)=CC4=CC=C3)=C2N=C1)NCCC6=NC=CS6
Synonyms :
Capzimin
MDL No. :MFCD31657375

Safety of Capzimin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF-10A 5 µM 24 hours No cytotoxicity observed Int J Mol Sci. 2022 Feb 28;23(5):2648.
MDA-MB 435S 5 µM 12 hours Induced cell death accompanied by cytoplasmic vacuolation Int J Mol Sci. 2022 Feb 28;23(5):2648.
A549 cells 10 µM 15 hours Capzimin induced the formation of aggresomes Nat Chem Biol. 2017 May;13(5):486-493.
BT549 5 µM 24 hours Reduced the viability and induced vacuolation prior to cell death Int J Mol Sci. 2022 Feb 28;23(5):2648.
Hela cells 5 µM 4 hours Capzimin caused accumulation of UbG76V-GFP Nat Chem Biol. 2017 May;13(5):486-493.
MDA-MB468 5 µM 24 hours Reduced the viability and induced vacuolation prior to cell death Int J Mol Sci. 2022 Feb 28;23(5):2648.
MDCK cells 0.001, 0.01, 0.1, 1, 10 µM 24 or 48 hours Capzimin exposure for 24 or 48 h at each cell line’s respective IC50 led to a slight increase in HIF1α Int J Mol Sci. 2022 Mar 17;23(6):3256.
Stromal-derived mesenchymal stem cells 0.001, 0.01, 0.1, 1, 10 µM 24 or 48 hours Capzimin exposure for 24 or 48 h at each cell line’s respective IC50 led to a slight increase in HIF1α Int J Mol Sci. 2022 Mar 17;23(6):3256.
Canine osteosarcoma cells OVC-cOSA-31 280 nM (IC50) 24 or 48 hours Evaluate the effect of Capzimin on apoptosis, results showed Capzimin induced apoptosis in OVC-cOSA-31 cells at 280 nM Int J Mol Sci. 2022 Mar 17;23(6):3256.
Canine osteosarcoma cells D17 400 nM (IC50) 24 or 48 hours Evaluate the effect of Capzimin on apoptosis, results showed Capzimin induced apoptosis in D17 cells at 400 nM Int J Mol Sci. 2022 Mar 17;23(6):3256.
Human osteosarcoma cells MG63.3 300 nM 6 days Evaluate the effect of Capzimin on human osteosarcoma cells under 3D culture conditions, results showed Capzimin significantly inhibited cell growth at 300 nM Int J Mol Sci. 2022 Mar 17;23(6):3256.
HCT116 cells 2 or 10 µM 6 hours Capzimin treatment caused accumulation of high molecular weight ubiquitin conjugates and the UPS substrates p53 and Hif1 α Nat Chem Biol. 2017 May;13(5):486-493.

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.59mL

0.32mL

0.16mL

7.95mL

1.59mL

0.80mL

15.90mL

3.18mL

1.59mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories